Table 3.
Odds ratios for increased arterial stiffness (brachial-ankle pulse wave velocity ≥14.0 m/s)
| Univariate |
Multivariate |
||||||
|---|---|---|---|---|---|---|---|
| Odds ratio | (95% CI) | p value | Odds ratio | (95% CI) | p value | ||
| sLOX-1 | 1.01 | (1.00–1.02) | 0.004 | 1.01 | (1.00–1.03) | 0.03 | |
| Sex | 1.20 | (0.47–3.09) | 0.69 | 6.27 | (0.62–63.44) | 0.12 | |
| Antihypertensive use | 4.64 | (1.32–16.25) | 0.01 | 4.69 | (0.45–49.10) | 0.19 | |
| Lipid-lowering agent use | 5.61 | (0.72–43.87) | 0.10 | 5.84 | (0.08–416.44) | 0.41 | |
| Other medication use | 0.92 | (0.40–2.08) | 0.83 | 0.49 | (0.10–2.42) | 0.37 | |
| Age | 1.25 | (1.14–1.36) | <0.0001 | 1.31 | (1.07–1.60) | 0.009 | |
| Body mass index | 0.98 | (0.85–1.13) | 0.75 | 0.81 | (0.58–1.13) | 0.21 | |
| Systolic blood pressure | 1.13 | (1.08–1.19) | <0.0001 | 1.40 | (1.16–1.69) | 0.0005 | |
| Diastolic blood pressure | 1.10 | (1.04–1.16) | 0.0005 | 0.87 | (0.72–1.04) | 0.12 | |
| Heart rate | 1.05 | (1.00–1.11) | 0.05 | 1.18 | (1.03–1.34) | 0.01 | |
| LDL | 0.98 | (0.97–1.00) | 0.02 | 1.00 | (0.96–1.03) | 0.77 | |
| HDL | 0.99 | (0.97–1.01) | 0.48 | 1.00 | (0.94–1.05) | 0.86 | |
| Triglycerides | 1.00 | (0.99–1.02) | 0.19 | 1.00 | (0.97–1.02) | 0.88 | |
| Glucose | 1.02 | (0.99–1.05) | 0.29 | 0.92 | (0.82–1.03) | 0.16 | |
| Hemoglobin A1c | 1.56 | (0.68–3.58) | 0.29 | 10.69 | (0.41–278.39) | 0.15 | |
| Insulin | 1.11 | (0.96–1.29) | 0.14 | 1.22 | (0.80–1.88) | 0.36 | |
CI, confidence interval; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; sLOX-1, soluble lectin-like oxidized low-density lipoprotein receptor-1.